Abstract
The structure-based design, chemical synthesis and in vitro activity evaluation of various falcipain inhibitors derived from 2-pyridone are reported. These compounds contain a peptidomimetic binding determinant and a Michael acceptor terminal moiety capable of deactivating the cysteine protease active site. (C) 2008 Elsevier Ltd. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 4210-4214 |
| Number of pages | 5 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 18 |
| Issue number | 14 |
| DOIs | |
| Publication status | Published - 15 Jul 2008 |
Keywords
- Cysteine protease
- Falcipain-2
- Malaria
- Peptidomimetic
- Plasmodium falciparum